Congress Moves to Classify Biotech as Critical Infrastructure
Proposed bipartisan bills require federal agencies to secure genetic and sensitive biometric data systems.
Updated on Oct. 21, 2026 in Biotech
Live Poll
Should the government treat private biotechnology data as critical infrastructure requiring federal oversight?
On September 24, 2026, the National Security Commission on Emerging Biotechnology introduced bipartisan legislation to classify biotechnology and biomanufacturing as critical infrastructure. The bills seek to protect vital biotech data and infrastructure from malicious actors through enhanced federal oversight.
Why it matters
The legislation aims to address national security vulnerabilities by formalizing the protection of genetic data systems against cyber threats. It empowers the Department of Homeland Security and CISA to manage risks associated with sensitive biological and biometric information.
The bills mandate the Department of Homeland Security develop a work plan within 45 days of enactment. Agencies must update strategic plans by September 30, 2027, followed by a mandated evaluation two years later.
The players
National Security Commission on Emerging Biotechnology
This body provides recommendations to the President and Congress on how to advance innovation in the biotechnology sector while maintaining national security.
Department of Homeland Security
This federal agency is responsible for public security, including the protection of national infrastructure from physical and cyber threats.
Cybersecurity and Infrastructure Security Agency
Known as CISA, this agency serves as the national coordinator for critical infrastructure security and resilience efforts.
The details
The proposed legislation tasks CISA with overseeing security management of genetic and sensitive biometric data systems while providing necessary training to federal personnel. The Department of Homeland Security must also identify key stakeholders and ensure their representation at coordinating councils to implement these new safeguards.
Timeline
September 24, 2026: The National Security Commission on Emerging Biotechnology announced the introduction of four bills.
Within 45 days of enactment: The Department of Homeland Security must develop and execute a required work plan.
September 30, 2027: This is the deadline to update strategic plans under the Homeland Security Act of 2002.
Within two years of the plan update: The Department of Homeland Security is scheduled to conduct a follow-up evaluation.
The Tech Race
This legislation updates the strategic framework established by the Homeland Security Act of 2002 to address modern biological security. By incorporating biotech into existing protection protocols, the government is playing catch-up with the rapid acceleration of digital genetic tools.
The bills will force increased security standards for research institutions and biotech firms handling genetic data. Consumers may see more rigorous privacy and data protection protocols applied to their sensitive biometric information over the coming years.
The takeaway
Securing biological infrastructure is becoming a central pillar of national security strategy as genetic data becomes more digitized. Industry players should prepare for a transition where biometric databases are subject to the same oversight as physical power or transit systems.
Further reading
For more on evolving standards, see the Biotech section.
Source note: This article includes information reported by The National Law Review - A Free To Use Nationwide Database of Legal Publications.
Live Poll
Should the government treat private biotechnology data as critical infrastructure requiring federal oversight?
